Immediate Impact

50 standout
Sub-graph 1 of 23

Citing Papers

New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors
2024 Standout
1 intermediate paper

Works of Sérgio A. Triginelli being referenced

Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer
2014
Total Inhibin Is a Potential Serum Marker for Epithelial Ovarian Cancer
2007

Author Peers

Author Last Decade Papers Cites
Sérgio A. Triginelli 199 124 97 112 27 345
Sambor Sawicki 181 89 85 115 43 370
Kyung‐Do Ki 165 86 107 107 31 389
Giusi Santangelo 124 66 88 77 37 354
Eun Young Ki 135 164 109 139 27 396
Linn Wölber 88 134 59 129 22 387
Sheila Segura 158 75 117 63 33 304
Hector M. Tarraza 179 164 154 69 22 408
Hiroshi Nanjyo 152 90 138 45 28 377
Kwang Sun Suh 95 82 54 94 27 333
Hidehiko Moromizato 212 145 86 113 23 345

All Works

Loading papers...

Rankless by CCL
2026